Gilead Sciences (GILD) stock Forecast for 2021 – 2025

Gilead Sciences (GILD) stock Forecast for 2022 – 2026

Last update: 05-19-2022, 14:09

Sector: Healthcare

The share price of Gilead Sciences, Inc. (GILD) now

What analysts predict:: $69.52

52-week high/low: $73.19 / $56.6

50/200 Day Moving Average: $60.64 / $66.67

This figure corresponds to the average price over the previous 50/200 days. For Gilead Sciences stocks, the 50-day moving average is the support level today.

For Gilead Sciences stocks, the 200-day moving average is the resistance level today.

Are you interested in Gilead Sciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Gilead Sciences stock price in 2022, 2023, 2024, 2025, 2026. How much will one Gilead Sciences share be worth in 2022 - 2026?

When should I take profit in Gilead Sciences stock? When should I record a loss on Gilead Sciences stock? What are analysts' forecasts for Gilead Sciences stock? What is the future of Gilead Sciences stock?

We forecast Gilead Sciences stock performance using neural networks based on historical data on Gilead Sciences stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Gilead Sciences stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Gilead Sciences shares. This happens once a day.




Historical and forecast chart of Gilead Sciences stock

The chart below shows the historical price of Gilead Sciences stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Gilead Sciences stock price can be found in the table below.

Long-term forecasts by years.

Gilead Sciences daily forecast for a month

Date Target Pes. Opt. Vol., %
May 21 64.32 63.86 64.69 1.29
May 22 64.23 63.99 64.42 0.69
May 23 64.46 64.24 64.90 1.02
May 24 63.75 63.21 64.07 1.36
May 25 63.91 63.41 64.10 1.10
May 26 64.18 63.61 64.46 1.33
May 27 63.80 63.47 64.16 1.09
May 28 63.67 63.20 63.90 1.11
May 29 64.32 63.91 64.59 1.05
May 30 64.40 63.94 64.72 1.21
May 31 63.64 63.22 63.84 0.99
Jun 01 63.77 63.37 64.32 1.49
Jun 02 63.96 63.61 64.13 0.81
Jun 03 63.88 63.44 64.42 1.55
Jun 04 63.82 63.56 64.08 0.82
Jun 05 64.45 63.98 64.69 1.10
Jun 06 64.08 63.54 64.58 1.65
Jun 07 64.64 64.49 65.06 0.89
Jun 08 64.12 63.82 64.66 1.31
Jun 09 63.68 63.20 64.17 1.54
Jun 10 63.59 63.28 63.75 0.74
Jun 11 63.69 63.30 64.16 1.35
Jun 12 63.59 63.16 64.17 1.59
Jun 13 63.82 63.35 64.04 1.10
Jun 14 63.71 63.55 63.89 0.54
Jun 15 64.35 64.16 64.83 1.03
Jun 16 64.66 64.09 65.19 1.71
Jun 17 64.08 63.91 64.38 0.73
Jun 18 63.74 63.52 64.11 0.93
Jun 19 63.69 63.52 64.12 0.94

Gilead Sciences Daily Price Targets


Gilead Sciences Stock Forecast 05-21-2022.

Forecast target price for 05-21-2022: $64.32. Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.277%.

Pessimistic target level: 63.86

Optimistic target level: 64.69


Gilead Sciences Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $64.23. Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 0.682%.

Pessimistic target level: 63.99

Optimistic target level: 64.42


Gilead Sciences Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $64.46. Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.013%.

Pessimistic target level: 64.24

Optimistic target level: 64.90


Gilead Sciences Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $63.75. Negative dynamics for Gilead Sciences shares will prevail with possible volatility of 1.337%.

Pessimistic target level: 63.21

Optimistic target level: 64.07


Gilead Sciences Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $63.91. Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.089%.

Pessimistic target level: 63.41

Optimistic target level: 64.10


Gilead Sciences Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $64.18. Positive dynamics for Gilead Sciences shares will prevail with possible volatility of 1.314%.

Pessimistic target level: 63.61

Optimistic target level: 64.46


GILD (GILD) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 64.30 62.63 66.50 5.82
Jul. 66.50 64.47 68.47 5.85
Aug. 67.38 65.42 69.31 5.60
Sep. 66.97 64.89 68.51 5.28
Oct. 64.27 62.57 65.52 4.50
Nov. 65.42 62.78 67.82 7.43
Dec. 64.72 62.21 65.51 5.04

Gilead Sciences forecast for this year


Gilead Sciences Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $64.3033. Pessimistic: $62.63. Optimistic: $66.50


Gilead Sciences Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $66.5005. Pessimistic: $64.47. Optimistic: $68.47


Gilead Sciences Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $67.3823. Pessimistic: $65.42. Optimistic: $69.31


Gilead Sciences Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $66.9699. Pessimistic: $64.89. Optimistic: $68.51


Gilead Sciences Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $64.2717. Pessimistic: $62.57. Optimistic: $65.52


Gilead Sciences Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $65.4189. Pessimistic: $62.78. Optimistic: $67.82


Gilead Sciences Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $64.7183. Pessimistic: $62.21. Optimistic: $65.51




Gilead Sciences (GILD) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 66.01 64.49 67.39 4.30
Feb 67.35 65.15 68.69 5.15
Mar 70.07 67.56 71.46 5.45
Apr 69.53 68.36 71.59 4.51
May 71.16 68.84 71.92 4.29
Jun 74.46 72.30 75.91 4.75
Jul 73.25 71.68 75.23 4.72
Aug 72.65 70.09 74.76 6.24
Sep 73.10 71.60 74.70 4.14
Oct 74.25 71.45 76.98 7.18
Nov 76.64 73.82 78.36 5.79
Dec 78.28 76.16 79.87 4.65

Gilead Sciences (GILD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 77.16 76.22 79.76 4.44
Feb 78.58 77.37 81.62 5.20
Mar 79.26 77.76 80.51 3.41
Apr 79.02 77.48 81.19 4.57
May 81.27 79.45 82.76 4.01
Jun 79.32 76.69 82.08 6.56
Jul 81.87 80.49 83.08 3.12
Aug 85.76 83.83 88.47 5.24
Sep 82.52 80.96 85.51 5.32
Oct 79.78 77.95 82.55 5.57
Nov 76.77 74.42 78.57 5.28
Dec 75.56 74.48 76.64 2.82



Gilead Sciences (GILD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 79.10 78.22 81.40 3.92
Feb 82.45 81.19 85.06 4.55
Mar 80.48 77.40 81.91 5.51
Apr 79.74 77.75 80.59 3.53
May 81.65 80.61 82.94 2.81
Jun 83.40 81.99 85.82 4.46
Jul 81.27 79.86 82.18 2.82
Aug 82.39 80.21 84.66 5.26
Sep 83.15 80.39 84.55 4.92
Oct 84.89 83.63 86.01 2.77
Nov 86.14 82.80 88.47 6.41
Dec 84.38 82.23 86.71 5.16

Gilead Sciences (GILD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 86.92 85.06 90.20 5.70
Feb 87.01 85.15 88.52 3.81
Mar 90.25 87.77 91.91 4.51
Apr 92.83 90.13 94.86 4.99
May 94.86 93.22 97.33 4.23
Jun 93.51 89.79 96.04 6.51
Jul 91.60 90.11 92.77 2.87
Aug 95.20 92.33 97.87 5.66
Sep 92.19 90.17 95.67 5.75
Oct 94.49 91.94 96.66 4.89
Nov 96.85 95.32 99.32 4.03
Dec 92.46 90.10 95.29 5.44

Gilead Sciences information and performance

Gilead Sciences is an American biopharmaceutical company that discovers, develops and markets innovative medicines. For many years since the firm opened, they have specialized mainly in antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza. The company is headquartered in Foster City, California, but has offices in North America, Europe and Australia.

Gilead Sciences was founded in June 1987 by a young physician, Michael Riordan. Michael worked with three key scientific advisors to start the company – Peter Derwan of the California Institute of Technology, Doug Melton of Harvard, and Harold Weintraub of the Fred Hutchinson Cancer Research Center. Riordan served as CEO from inception until 1996. He was most interested in the antiviral business, as he contracted dengue himself. In 2006, the company made two acquisitions, which allowed it to expand into not only antiviral drugs, but also drugs in the field of cardiovascular and respiratory diseases.

Official site of the company

Gilead Sciences Address

333 LAKESIDE DR, FOSTER CITY, CA, US

Market Capitalization: 78 068 261 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 13 186 500 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 17.39

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0.533

Price/earnings to growth

DPS: 2.86

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0468

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 3.58

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.989

Quarterly Revenue Growth YOY: 0.026

Trailing PE: 17.39

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 9.64

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.608

Enterprise Value (EV) /Revenue

EV To EBITDA: 11.08

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1254310000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A


Gilead Sciences (GILD) stock dividend

Gilead Sciences last paid dividends on 06/14/2022. The next scheduled payment will be on 06/29/2022. The amount of dividends is $2.86 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.